Janney Montgomery Scott’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.6M Sell
311,826
-8,029
-3% -$1.23M 0.12% 176
2025
Q4
$44.1M Buy
319,855
+6,573
+2% +$861K 0.1% 199
2025
Q3
$40.2M Buy
313,282
+2,893
+0.9% +$353K 0.1% 208
2025
Q2
$37.6M Buy
310,389
+86,351
+39% +$9.73M 0.1% 209
2025
Q1
$25M Sell
224,038
-25,584
-10% -$2.72M 0.07% 272
2024
Q4
$24.3M Buy
249,622
+4,624
+2% +$493K 0.07% 285
2024
Q3
$28.2M Sell
244,998
-3,913
-2% -$444K 0.08% 263
2024
Q2
$26.5M Sell
248,911
-3,850
-2% -$386K 0.08% 256
2024
Q1
$24.4M Sell
252,761
-6,795
-3% -$697K 0.07% 271
2023
Q4
$26.2M Sell
259,556
-7,345
-3% -$709K 0.09% 236
2023
Q3
$27.2M Sell
266,901
-10,995
-4% -$1.12M 0.1% 192
2023
Q2
$28M Buy
277,896
+4,928
+2% +$493K 0.1% 199
2023
Q1
$25.1M Sell
272,968
-32,341
-11% -$2.82M 0.1% 192
2022
Q4
$27.7M Buy
305,309
+5,673
+2% +$478K 0.11% 183
2022
Q3
$22.8M Buy
299,636
+4,840
+2% +$401K 0.1% 203
2022
Q2
$24.9M Buy
294,796
+2,235
+0.8% +$196K 0.11% 187
2022
Q1
$25.7M Buy
292,561
+46,946
+19% +$4.06M 0.11% 190
2021
Q4
$21.5M Sell
245,615
-1,599
-0.6% -$133K 0.08% 218
2021
Q3
$20.2M Buy
247,214
+9,389
+4% +$845K 0.09% 217
2021
Q2
$21.7M Buy
237,825
+7,150
+3% +$637K 0.1% 198
2021
Q1
$19.7M Sell
230,675
-1,519
-0.7% -$136K 0.1% 199
2020
Q4
$21.9M Sell
232,194
-8,433
-4% -$737K 0.11% 187
2020
Q3
$20.9M Sell
240,627
-4,812
-2% -$417K 0.12% 173
2020
Q2
$21.4M Sell
245,439
-9,365
-4% -$808K 0.14% 170
2020
Q1
$21M Sell
254,804
-2,550
-1% -$228K 0.17% 148
2019
Q4
$24.4M Buy
257,354
+9,103
+4% +$817K 0.16% 150
2019
Q3
$21.6M Buy
248,251
+5,423
+2% +$487K 0.16% 155
2019
Q2
$22.2M Sell
242,828
-13,562
-5% -$1.15M 0.17% 140
2019
Q1
$22.1M Buy
256,390
+15,617
+6% +$1.25M 0.18% 135
2018
Q4
$18.5M Buy
240,773
+6,256
+3% +$487K 0.18% 130
2018
Q3
$18.1M Buy
234,517
+27,466
+13% +$2.03M 0.16% 145
2018
Q2
$14M Sell
207,051
-1,317
-0.6% -$90.9K 0.13% 177
2018
Q1
$15.1M Buy
208,368
+10,888
+6% +$829K 0.15% 152
2017
Q4
$14.9M Buy
197,480
+13,843
+8% +$1.04M 0.15% 155
2017
Q3
$14.1M Buy
183,637
+9,732
+6% +$735K 0.16% 145
2017
Q2
$13M Sell
173,905
-2,455
-1% -$174K 0.16% 147
2017
Q1
$11.7M Buy
176,360
+31,147
+21% +$2.08M 0.16% 156
2016
Q4
$9.48M Buy
145,213
+68,564
+89% +$4.45M 0.14% 177
2016
Q3
$5.42M Buy
+76,649
New +$5.59M 0.1% 232
2016
Q2
Sell
-64,285
Closed -$4.17M 1009
2016
Q1
$4.17M Sell
64,285
-17,175
-21% -$1.17M 0.11% 196
2015
Q4
$6.28M Sell
81,460
-8,194
-9% -$651K 0.16% 152
2015
Q3
$7.38M Buy
89,654
+6,936
+8% +$617K 0.21% 116
2015
Q2
$7.29M Buy
82,718
+5,006
+6% +$459K 0.15% 153
2015
Q1
$6.87M Buy
77,712
+4,971
+7% +$441K 0.13% 196
2014
Q4
$6.04M Buy
72,741
+4,349
+6% +$360K 0.12% 208
2014
Q3
$5.77M Buy
68,392
+7,839
+13% +$634K 0.12% 207
2014
Q2
$4.91M Buy
60,553
+13,668
+29% +$1.08M 0.11% 228
2014
Q1
$3.57M Buy
46,885
+1,810
+4% +$132K 0.09% 289
2013
Q4
$3.25M Sell
45,075
-6,100
-12% -$424K 0.09% 285
2013
Q3
$3.52M Buy
51,175
+42,423
+485% +$2.81M 0.11% 228
2013
Q2
$555K Buy
+8,752
New +$569K 0.06% 375

Other funds holding NVS

Janney Montgomery Scott's NVS Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Novartis (NVS) stake by 2.5% in Q1 2026, selling an estimated $1.23M and leaving 311,826 shares worth $47.6M. The position accounts for 0.12% of the portfolio, ranked #176.

Janney Montgomery Scott first reported a position in NVS in Q2 2013 and has held it in 51 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Janney Montgomery Scott held 311,826 shares of Novartis worth $47.6M as of Q1 2026.
  • Janney Montgomery Scott sold 8,029 Novartis shares in Q1 2026, an estimated $1.23M.
  • Novartis made up 0.12% of Janney Montgomery Scott's portfolio in Q1 2026, its #176 holding.
  • Janney Montgomery Scott first reported a position in Novartis in Q2 2013 and has held it in 51 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.